Contact
Tirzepatide

Same active ingredient as

Mounjaro® & Zepbound®

Tirzepatide

Tirzepatide, marketed as Zepbound, is approved by the FDA for chronic weight management. As a dual-agonist medication, Tirzepatide combines the effects of GLP-1 and GIP receptor agonists, offering an advanced approach to weight loss. Clinical trials have demonstrated impressive results, making Tirzepatide a highly effective option for individuals seeking significant weight reduction and improved health outcomes.


What is Tirzepatide?

Tirzepatide is a once-weekly injection that activates both GLP-1 (Glucagon-like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors. These hormones play a crucial role in regulating blood sugar levels, suppressing appetite, and enhancing feelings of fullness, making Tirzepatide a powerful tool in weight management.

How Does Tirzepatide Work?

Tirzepatide targets both GIP and GLP-1 pathways, offering multiple benefits for weight loss:

  • Blood Sugar Regulation: Decreases sugar production by the liver and increases insulin production.
  • Appetite Suppression: Reduces cravings and hunger by mimicking natural hormones.
  • Enhanced Satiety: Slows down digestion, prolonging feelings of fullness and satisfaction.

FDA Approval for Weight Loss

Yes, Tirzepatide is FDA-approved for weight loss under the brand name Zepbound. It is also approved for managing type 2 diabetes under the brand name Mounjaro.

Who is Tirzepatide For?

Tirzepatide (Zepbound) is indicated for:

  • Adults with obesity.
  • Adults with excess weight and weight-related medical problems.
  • Adults with type 2 diabetes (marketed as Mounjaro).

Exclusions:

  • Individuals with a history of pancreatitis.
  • Those under 18 years of age.
  • Breastfeeding individuals.
  • Patients with type 1 diabetes.
  • Pregnant or planning-to-be pregnant individuals.
  • Individuals or families with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Potential Side Effects

Common side effects, usually mild-to-moderate, include:

  • Nausea and vomiting
  • Diarrhea
  • Stomach pain
  • Constipation
  • Fatigue

Less common but more serious side effects may include severe stomach problems, kidney issues, gallbladder problems, and pancreatitis. For a full list of potential side effects, please refer to the medication insert.

Our Tirzepatide dosing:

  • 2.5 mg dose
  • 5 mg dose
  • 7.5 mg dose
  • 10 mg dose

Do I Qualify for Tirzepatide?

To determine if Tirzepatide is right for you, our providers will review a simple questionnaire. Basic recommendations include:

  • An initial BMI of 30 or greater.
  • An initial BMI of 27 to 29.9 with at least one additional weight-related health issue (e.g., high blood pressure, high cholesterol, triglycerides, diabetes, or pre-diabetes).

Check Your BMI Now


Why Choose Phoenix Weight Loss and Wellness?

At Phoenix Weight Loss and Wellness, medical weight loss is our sole focus. Our dedicated team of doctors, nurses, and medical assistants is committed to supporting your journey. We offer:

  • Personalized, affordable Tirzepatide programs.
  • One-on-one coaching.
  • Comprehensive weight loss support and education.

You can reach out to us via email, phone, or in-person appointments for any questions or concerns. Your health is personal, and finding a provider you trust is essential. Choose Phoenix Weight Loss and Wellness for a supportive, expert-led weight loss experience.

References

  1. Jastreboff, Ania M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 
  2. FDA Office of Media Affairs (2023). FDA Approves New Medication for Chronic Weight Management. FDA.gov.
  3. FDA Office of Media Affairs (2022). FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes. FDA.gov.
  4. Eli Lilly. (2023). Zepbound [package insert].

Hi.

How can we help?

Contact